eprintid: 96376
rev_number: 3
eprint_status: archive
dir: disk0/00/09/63/76
datestamp: 2026-06-19 05:23:37
lastmod: 2026-06-19 05:23:37
status_changed: 2026-06-19 05:23:37
type: article
metadata_visibility: show
creators_name: Kurbanova, Z.Ch
creators_name: Babadjanov, S.A
creators_name: Begmatova, U.A
title: IMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS
ispublished: pub
keywords: Immune-mediated microvascular thrombosis, anticoagulant therapy, hemostatic parameters, D-dimer, fibrinogen, C-reactive protein, interleukin-6.
abstract: Immune-mediated microvascular thrombosis (IMMT) is a complex disorder driven by immune dysregulation, leading to microvascular occlusion and necessitating anticoagulant therapy. This study evaluates the impact of anticoagulant therapy on hemostatic parameters (D-dimer, fibrinogen, prothrombin time [PT], activated partial thromboplastin time [APTT]) and inflammatory markers (C-reactive protein [CRP], interleukin-6 [IL-6]) in 45 patients with IMMT. Patients were followed for 12 months, receiving either warfarin or direct oral anticoagulants (DOACs). D-dimer levels decreased significantly (1.5 µg/mL to 0.6 µg/mL, p<0.01), with DOACs showing greater reduction (p=0.02). Fibrinogen remained elevated in 60% of patients (mean 4.3 ± 0.9 g/L), correlating with CRP (r=0.65, p<0.01). IL-6 levels declined from 12.5 pg/mL to 5.8 pg/mL (p<0.05), reflecting reduced inflammation. Thrombotic recurrence occurred in 18% of patients, associated with persistent fibrinogen elevation (OR 2.9, 95% CI 1.1–7.6, p=0.03). These findings highlight the role of hemostatic and inflammatory markers in monitoring therapy efficacy and predicting outcomes in IMMT, supporting personalized treatment approaches.
date: 2025-05-17
official_url: https://universalconference.us/index.php/crismw/article/view/4428
full_text_status: public
publication: CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD
volume: 2
number: 5
pagerange: 137-142
citation:   Kurbanova, Z.Ch, Babadjanov, S.A, Begmatova, U.A  (2025) IMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS.  CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD, 2 (5).  pp. 137-142.      
document_url: https://arxiv.universalpublishings.com/id/eprint/96376/1/137-142.pdf